Who
Gautam Patel
Director
Company insider
Files Form 4 as: Director and 10% owner, Amneal Pharmaceuticals; Director, Spectrum Brands Holdings.
In numbers
- Trades disclosed
- 60
- Buys
- 3
- Sells
- 9
- Bought
- $800K
- Sold
- $4.0M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 7 May 2018
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —283,632 | filing |
| 10 Aug 2026filed 12 Aug 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —283,632 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,819 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,819 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,824 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | SPB Spectrum Brands HoldingsElectronic Components & EMS | SEC FORM 4 Code A | —4,602 at $0.00 | filing |
| 16 Jun 2025filed 18 Jun 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $761K94,906 at $8.02 | filing |
| 10 Jun 2025filed 12 Jun 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $453K56,426 at $8.02 | filing |
| 6 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,819 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —40,258 at $0.00 | filing |
| 5 May 2025filed 8 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —40,258 | filing |
| 5 May 2025filed 6 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $39K4,900 at $8.00 | filing |
| 2 May 2025filed 6 May 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $30K3,768 at $8.00 | filing |
| 1 Apr 2025filed 2 Apr 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $664K80,000 at $8.30 | filing |
| 3 Mar 2025filed 5 Mar 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $712K80,000 at $8.90 | filing |
| 3 Feb 2025filed 5 Feb 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $651K80,000 at $8.14 | filing |
| 8 Jan 2025filed 10 Jan 2025 | AMRX Amneal PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $501K62,590 at $8.01 | filing |
News
No headline names them, or the companies they trade most, lately.